HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hb Evora [alpha2-35 (B16), Ser-->Pro], a novel hemoglobin variant associated with an alpha-thalassemia phenotype.

Abstract
We report a novel mutation in the alpha2-globin gene, codon 35 (T-->C), detected in two unrelated Portuguese families. This mutation gives rise to a previously undescribed hemoglobin (Hb) variant, which we named Hb Evora. This variant seems to be responsible for the alpha-thalassemia phenotype present in its carriers. It cannot be detected by conventional laboratory techniques, probably because of its highly unstable nature.
AuthorsSusana Gomes, Isabel Picanço, Armandina Miranda, Maria Teresa Seixas, Mafalda Oliveira, Luísa Romão, Paula Faustino
JournalHaematologica (Haematologica) Vol. 92 Issue 2 Pg. 252-3 (Feb 2007) ISSN: 1592-8721 [Electronic] Italy
PMID17296578 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins
  • Hemoglobins, Abnormal
Topics
  • Adult
  • Child
  • Child, Preschool
  • Family Health
  • Female
  • Hemoglobins (genetics, physiology)
  • Hemoglobins, Abnormal (genetics)
  • Heterozygote
  • Humans
  • Male
  • Mutation
  • Phenotype
  • Polymerase Chain Reaction
  • Portugal
  • alpha-Thalassemia (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: